Evidence map›Paper›PMID 29568579›Full record

ArticleSouthern African journal of HIV medicine2015

Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment.

Marlene Knight, Robyn L van Zyl, Ian Sanne, Jean Bassett, Annelies van Rie

Open access · goldAbstract read
In one paragraph

Article in Southern African journal of HIV medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marlene KnightClinical HIV Research Unit, University of the Witwatersrand, South Africa.
Robyn L van ZylDepartment of Pharmacy and Pharmacology, University of the Witwatersrand, South Africa.
Ian SanneRight to Care, Johannesburg, South Africa.
Jean BassettWitkoppen Health and Welfare Centre, Johannesburg, South Africa.
Annelies van RieDepartment of Epidemiology, University of North Carolina, United States.
University of the Witwatersrand · ZARight to Care · ZA

Funding

Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplicationUM1AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI REES, HELEN, SANNE, IAN MATTHIAS · 2012 to 2025
$31.8M
NIAID NIH HHS UM1 AI069463
6 · The paper itself

Abstract

backgroundHealthcare workers are often reluctant to start combination antiretroviral therapy (ART) in patients receiving tuberculosis (TB) treatment because of the fear of high pill burden, immune reconstitution inflammatory syndrome, and side-effects. OBJECT: To quantify changes in adherence to tuberculosis treatment following ART initiation.

designA prospective observational cohort study of ART-naïve individuals with baseline CD4 count between 50 cells/mm

resultsART tended to negatively affect adherence to TB treatment, with an 8% - 10% decrease in the proportion of patients adherent according to pill count and an 18% - 22% decrease in the proportion of patients adherent according to eMEMS in the first month following ART initiation, independent of the cut-off used to define adherence (90%, 95% or 100%). Reasons for non-adherence were multifactorial, and employment was the only predictor for optimal adherence (adjusted odds ratio 4.11, 95% confidence interval 1.06-16.0).

conclusionAdherence support in the period immediately following ART initiation could optimise treatment outcomes for people living with TB and HIV.

Identifiers

PMID29568579
PMCPMC5850563
OpenAlexW1821014330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.